Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • BRS Venture Plans to...

    BRS Venture Plans to invest Rs 2193 crore to acquire Indian Hospitals

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 28 Oct 2018 3:45 AM  |  Updated On 16 Aug 2021 10:43 AM
    New Delhi: The UAE-based USD 3 billion BRS Ventures plans to acquire hospitals in India, as it looks to consolidate its healthcare practice. BRS Ventures through BR Life, which is a holding company for Indian healthcare enterprises, plans to invest USD 300 million in the country to acquire hospitals in various cities. "Our strategy is to acquire a majority stake in hospitals or fully acquire them, invest back and expand their operations," Binay R Shetty, Vice-Chairman and CEO, BRS Ventures.

    BRS Ventures operates across eight main sectors, including healthcare. In the healthcare vertical, it has three separate entities, including NMS Royal Hospital, which owns a 3000-bed hospital in Abu Dhabi and is listed on the London Stock Exchange, with a market valuation of USD 10 billion. In India, BR Life has acquired five hospitals with total bed strength of 1500.

    "We expect to grow that to about 10,000 beds in another five years, which is comparable to any big hospital chain," said Shetty. Shetty said the focus of the company is to provide affordable, high-quality health care and add value to the acquired properties. He said that acquisition of a large chain of hospitals can be challenging as it involves changing their culture. "We are not looking at profitability as our focus but want to add value, and we consider ourselves as long-term players in India," he said. The group also runs a financial services company, Unimoni, which focuses on inward remittances. In India, it handles 10 per cent of inward remittances, with a total of about USD 7 billion.

    Read Also: UAE based NMC Healthcare highest bidder for SevenHills hospital: Report

    Binay R ShettyBR LifeBRS VentureHealthcareNMS Royal Hospital

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok